Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia.

Cell Death Dis · 2018 · PMC6113287 · PMID 30154435

Europe PMC DOI

hedged sentence

0.0576

closest p · 1.2× alpha

0.0576

boldest claim

The sentences

did not reach statistical significanceP = 0.0576so close (0.05 < p ≤ 0.1)

In addition, we found that AF1q overexpression increased engraftment of CML cells in vivo and reduced survival of mice transplanted with CML cells, although this difference did not reach statistical significance ( P = 0.0576).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.